Clinical trial

Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes

NCT06723795

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-03-01

PhaseNA

Study timeline

Study start (actual)2025-03-01Date precision: day

Registry last updated2026-08-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPD (Chronic Obstructive Pulmonary Disease)unresolved

Cardiovascular Diseasesunresolved

Interventions

Cardiologist evaluationOTHER

Pulmonologist evaluationOTHER

Sponsors & collaborators

Tel-Aviv Sourasky Medical Centerlead sponsor

AstraZenecacollaborator

Mapped research locations

Tel AvivIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06723795 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.